Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers var...
Aligos Therapeutics receives USD 25 million upfront in Greater China pevifoscorvir license deal with Amoytop
Aligos 10-K: Revenue $2.19M, EPS (2.45) — 2025 Annual Filing
Asian Value Stock Picks For Intrinsic Valuation Estimates January 2026
3 Asian Stocks Estimated To Be 35.9% To 49.2% Below Intrinsic Value
3 Asian Stocks Estimated To Be Undervalued In January 2026
Asian Market Stocks Estimated Up To 26% Below Intrinsic Value